Professional Documents
Culture Documents
uk
Symptoms
People in the early stages of Alzheimers disease may experience lapses of memory and have problems nding the right words. As the disease progresses, they may: become confused and frequently forget the names of people, places, appointments and recent events experience mood swings, feel sad or angry, or scared and frustrated by their increasing memory loss become more withdrawn, due either to a loss of condence or to communication problems have difculty carrying out everyday activities they may get muddled checking their change at the shops or become unsure how to work the TV remote. As the disease progresses, people with Alzheimers will need more support from those who care for them. Eventually, they will need help with all their daily activities. While there are some common symptoms of Alzheimers disease, it is important to remember that everyone is unique. No two people are likely to experience Alzheimers disease in the same way.
Environmental factors The environmental factors that may contribute to the onset of Alzheimers disease have yet to be identied. A few years ago, there were concerns that exposure to aluminium might cause Alzheimers disease. However, these fears have largely been discounted. Other factors Because of the difference in their chromosomal make-up, people with Downs syndrome who live into their 50s and 60s are at particular risk of developing Alzheimers disease. People who have had severe head or whiplash injuries also appear to be at increased risk of developing dementia. Boxers who receive continual blows to the head are at risk too. Research has also shown that people who smoke, and those who have high blood pressure, high cholesterol levels or diabetes, are at increased risk of developing Alzheimers. You can help reduce your risk by not smoking, eating a healthy balanced diet and having regular checks for blood pressure and cholesterol from middle age. Maintaining a healthy weight and leading an active lifestyle combining physical, social and mental activity will also help.
Getting a diagnosis
If you are concerned about your own health, or the health of someone close to you, it is important to seek help from a GP. An early diagnosis will have a number of benets including the opportunity to plan for the future and access treatment, advice and support. There is no straightforward test for Alzheimers disease or for any other cause of dementia. A diagnosis is usually made by excluding other causes which present similar symptoms. The GP will need to rule out conditions such as infections, vitamin deciency, thyroid problems, depression and the side-effects of medication.
Specialists The GP may ask a specialist for help in carrying out a diagnosis. The specialist may be an old-age psychiatrist, a neurologist, a physician in geriatric medicine or a general psychiatrist. Who the person sees will depend on their age, how physically able they are and how well services are developed in the local area. Tests The person being tested will usually be given a blood test and a full physical examination to rule out or identify any other medical problems. The persons memory will be assessed, initially with questions about recent events and past memories. Their memory and thinking skills may also be assessed in detail by a psychologist. A brain scan may be carried out to give some clues about the changes taking place in the persons brain. There are a number of different types of scan, including computerised tomography (CT) and magnetic resonance imaging (MRI).
Treatment
There is currently no cure for Alzheimers disease. However, drug treatments are available that can temporarily alleviate some symptoms or slow down their progression in some people. People with Alzheimers have been shown to have a shortage of the chemical acetylcholine in their brains. The drugs Aricept, Exelon and Reminyl (trade names for the drugs donepezil hydrochloride, rivastigmine and galantamine) work by maintaining existing supplies of acetylcholine. As of March 2011, these drugs are recommended as an option for people in the mild-to-moderate stages of Alzheimers disease. Please refer to the National Institute for Health and Clinical Excellence (NICE) website for guidance (see Useful organisations at the end of this factsheet). Side-effects are usually minor but may include diarrhoea, nausea, insomnia, fatigue and loss of appetite.
A drug called Ebixa (trade name for the drug memantine) was launched in the UK in 2002. Ebixa works in a different way from the other three and is the only drug that is recommended for people in both the moderate and severe stages of Alzheimers disease. Sideeffects may include dizziness, headaches and tiredness, and rarely hallucinations or confusion. These drugs are not a cure, but they may stabilise some of the symptoms of Alzheimers disease for a limited period, typically 612 months or longer.
Useful organisations
Carers UK 20 Great Dover Street London SE1 4LX T 0808 808 7777 (free carers line, Wednesday and Thursday 10am12pm and 2pm4pm) E info@carersuk.org W www.carersuk.org Provides information and advice to carers about their rights, and how to access support. National Institute for Health and Clinical Excellence (NICE) MidCity Place 71 High Holborn London WC1V 6NA T 0845 003 7780 E nice@nice.org.uk W www.nice.org.uk Provides national guidance on promoting good health and preventing and treating ill health. It produces guidance on public health, health technologies, and on appropriate treatment and care of people with specic diseases and conditions within the NHS. For the most up-todate information on Alzheimers treatments, see their website.
This publication contains information and general advice. It should not be used as a substitute for personalised advice from a qualied professional. Alzheimers Society does not accept any liability arising from its use. We strive to ensure that the content is accurate and up to date, but information can change over time. Please refer to our website for the latest version and for full terms and conditions. Alzheimers Society, 2013. All rights reserved. Except for personal use, no part of this work may be distributed, reproduced, downloaded, transmitted or stored in any form without the written permission of Alzheimers Society.
Factsheet 401LP Last reviewed: April 2011 Last updated: March 2012 Next review due: April 2013 Reviewed by: Professor Steve Iliffe, Professor of Primary Care for Older People, University College London and Professor Jenny Rusted, Professor of Experimental Psychology, University of Sussex This factsheet has also been reviewed by people affected by dementia. A list of sources is available on request.
Alzheimers Society National Dementia Helpline England, Wales and Northern Ireland: 0300 222 11 22 9am5pm MondayFriday 10am4pm SaturdaySunday alzheimers.org.uk Alzheimers Society is the UKs leading support and research charity for people with dementia, their families and carers.
Registered charity no. 296645. A company limited by guarantee and registered in England no. 2115499